Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RCGD423 是一种gp130调节剂,能阻断关节软骨的退化,并诱导其修复。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 256 | 现货 | ||
5 mg | ¥ 595 | 现货 | ||
10 mg | ¥ 913 | 现货 | ||
25 mg | ¥ 1,530 | 现货 | ||
50 mg | ¥ 2,390 | 现货 | ||
100 mg | ¥ 3,570 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 657 | 现货 |
产品描述 | RCGD423, a small molecule gp130 modulator, prevents articular cartilage degeneration and promotes repair. |
体外活性 | The ability of RCGD 423 to inhibit hypertrophy in human cells was confirmed by assessing RUNX2 and COL 10 levels in healthy and osteoarthritic articular chondrocytes following incubation with the compound. RCGD 423 elicited a unique signaling profile, driving strong increases in pSTAT3 and MYC levels without activating AKT or NF-κB, resulting in a signaling milieu downstream of gp130 similar to actively proliferating and anabolic fetal chondrocytes. |
体内活性 | Operated animals would receive an intra-articular injection of 4 μg RCGD 423 loaded onto microspheres at the time of surgery and another 3weeks later. In RCGD 423-treated animals, there was little to no cartilage degradation, structural damage or generation of osteophytes. Control animals showed increased levels of cartilage-degrading proteins and markers of hypertrophy, while these were mostly absent in RCGD 423-treated rats. |
分子量 | 331.23 |
分子式 | C15H11BrN2S |
CAS No. | 108237-91-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Insoluble
DMSO: 150 mg/mL (452.86 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.0191 mL | 15.0953 mL | 30.1905 mL | 75.4763 mL |
5 mM | 0.6038 mL | 3.0191 mL | 6.0381 mL | 15.0953 mL | |
10 mM | 0.3019 mL | 1.5095 mL | 3.0191 mL | 7.5476 mL | |
20 mM | 0.151 mL | 0.7548 mL | 1.5095 mL | 3.7738 mL | |
50 mM | 0.0604 mL | 0.3019 mL | 0.6038 mL | 1.5095 mL | |
100 mM | 0.0302 mL | 0.151 mL | 0.3019 mL | 0.7548 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
RCGD423 108237-91-8 Immunology/Inflammation Interleukin RCGD-423 inhibit Inhibitor Interleukin Related RCGD 423 inhibitor